Global OTC Cold and Cough Medicines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global OTC Cold and Cough Medicines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescription. The drugs for the treatment of cold and cough acts on the receptors to which the virus causing the infection gets attached to, by antagonizing the action of the receptors and killing the viral infection, thereby reducing congestion by lysing the mucus and dilating the bronchioles constricted by the mucus deposition. Cold weather is not directly associated with common cold, but the virus which causes common cold, called rhinovirus, is responsible for all cold related illnesses. Once the virus is inhaled, it attaches to the cells in nasal passages.
OTC Cold and Cough Medicines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global OTC Cold and Cough Medicines market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for OTC Cold and Cough Medicines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, OTC Cold and Cough Medicines key manufacturers include Sanofi-Aventis, Johnson & Johnson, Reckitt Benckiser Group Plc., Novartis AG, GlaxoSmithKline Plc., AstraZeneca Plc., Pfizer Inc., Sun Pharmaceutical and Prestige Brands Holdings, Inc., etc. Sanofi-Aventis, Johnson & Johnson, Reckitt Benckiser Group Plc. are top 3 players and held % sales share in total in 2022.
OTC Cold and Cough Medicines can be divided into Pellets, Drops, Tablets and Capsules, etc. Pellets is the mainstream product in the market, accounting for % sales share globally in 2022.
OTC Cold and Cough Medicines is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the OTC Cold and Cough Medicines industry development. In 2022, global % sales of OTC Cold and Cough Medicines went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Cold and Cough Medicines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
Sanofi-Aventis
Johnson & Johnson
Reckitt Benckiser Group Plc.
Novartis AG
GlaxoSmithKline Plc.
AstraZeneca Plc.
Pfizer Inc.
Sun Pharmaceutical
Prestige Brands Holdings, Inc.
Procter & Gamble Co.
Segment by Type
Pellets
Drops
Tablets
Capsules
Powders
Sprays
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the OTC Cold and Cough Medicines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of OTC Cold and Cough Medicines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the OTC Cold and Cough Medicines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of OTC Cold and Cough Medicines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, OTC Cold and Cough Medicines introduction, etc. OTC Cold and Cough Medicines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of OTC Cold and Cough Medicines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.![](http://localhost/mraccuracy/images/About Report.webp)
OTC Cold and Cough Medicines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global OTC Cold and Cough Medicines market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for OTC Cold and Cough Medicines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, OTC Cold and Cough Medicines key manufacturers include Sanofi-Aventis, Johnson & Johnson, Reckitt Benckiser Group Plc., Novartis AG, GlaxoSmithKline Plc., AstraZeneca Plc., Pfizer Inc., Sun Pharmaceutical and Prestige Brands Holdings, Inc., etc. Sanofi-Aventis, Johnson & Johnson, Reckitt Benckiser Group Plc. are top 3 players and held % sales share in total in 2022.
OTC Cold and Cough Medicines can be divided into Pellets, Drops, Tablets and Capsules, etc. Pellets is the mainstream product in the market, accounting for % sales share globally in 2022.
OTC Cold and Cough Medicines is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the OTC Cold and Cough Medicines industry development. In 2022, global % sales of OTC Cold and Cough Medicines went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Cold and Cough Medicines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
Sanofi-Aventis
Johnson & Johnson
Reckitt Benckiser Group Plc.
Novartis AG
GlaxoSmithKline Plc.
AstraZeneca Plc.
Pfizer Inc.
Sun Pharmaceutical
Prestige Brands Holdings, Inc.
Procter & Gamble Co.
Segment by Type
Pellets
Drops
Tablets
Capsules
Powders
Sprays
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the OTC Cold and Cough Medicines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of OTC Cold and Cough Medicines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the OTC Cold and Cough Medicines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of OTC Cold and Cough Medicines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, OTC Cold and Cough Medicines introduction, etc. OTC Cold and Cough Medicines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of OTC Cold and Cough Medicines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
![](http://localhost/mraccuracy/images/About Report.webp)